BioAlliance Pharma appoint chef executive officer

Published: 15-Oct-2007

A member of the BioAlliance Pharma scientific board has been appointed to the position of chief executive officer within the company.


A member of the BioAlliance Pharma scientific board has been appointed to the position of chief executive officer within the company.

Professor Christian Auclair has been a member of the scientific board for six years and has introduced a number of projects to the company, including the development of HIV-I intergrase inhibitors, and the development of non-cytotoxic actin cytoskeleton modulators exhibiting anti-invasive properties.

He currently works as director of biotechnology and applied genetic pharmacology laboratory at a leading Paris region university. Under his new appointment, Auclair will manage internal working groups involved in priority projects with strategic partners such as CNRS, Inserm, universities and the Institut Gustave Roussy.

You may also like